The Federal Trade Commission will hold two roundtables on emerging health care competition and consumer issues. They will focus on two distinct areas in which competition and consumer protection policies are implicated: (1) competition among health care providers based on quality information; and (2) competition provided by developing an abbreviated regulatory approval pathway for follow-on biologic drugs.
FOR FURTHER INFORMATION
For questions related to the workshop, contact:
Bureau of Competition,
600 Pennsylvania Avenue, N.W.,
Washington, D.C. 20580
Phone (202) 326-2435
Transcript - Files
Request for Comments
The Commission invites interested persons to submit written comments on issues related to this workshop. All comments in response to the Federal Register Notice [PDF] are due by September 30, 2008. In addition, any interested person may submit written comments to any of the topics addressed during the workshops. Comments directed at a particular subject considered in a workshop or roundtable must be submitted not later than 30 days after the date of that workshop or roundtable.
Comments should be captioned “Emerging Health Care Competition and Consumer Issues – Comment, Project No. P083901” and be submitted according to the instructions below.
To File Electronically:
Comments filed in electronic form should be submitted by using the following weblink: http://secure.commentworks.com/ftc-healthcarecompetition and following the instructions on the web-based form.
To File in Paper Form:
Include “Emerging Health Care Competition and Consumer Issues – Comment, Project No. P083901” both in the text and on the envelope, and mail or deliver to the following address:
Federal Trade Commission/Office of the Secretary
600 Pennsylvania Avenue, N.W.
Room H-135 (Annex F)
Washington, DC 20580
Because postal mail in the Washington area and at the Commission is subject to delay, please consider submitting your comments in electronic form, as prescribed above. The FTC requests that you send any comment by courier or overnight service, if possible.
To Request Confidential Treatment:
Comments containing material for which confidential treatment is requested must be filed in paper form, must be clearly labeled “Confidential,” and must comply with Commission Rule 4.9(c). Comments should not include any sensitive personal information, such as an individual’s Social Security Number; date of birth; driver’s license number or other state identification number or foreign country equivalent; passport number; financial account number; or credit or debit card number. Comments also should not include any sensitive health information, such as medical records and other individually identifiable health information.